225 related articles for article (PubMed ID: 27538585)
1. Meta-analysis of long-term joint structural deterioration in minimally treated patients with rheumatoid arthritis.
Jansen JP; Vieira MC; Bradley JD; Cappelleri JC; Zwillich SH; Wallenstein GV
BMC Musculoskelet Disord; 2016 Aug; 17(1):348. PubMed ID: 27538585
[TBL] [Abstract][Full Text] [Related]
2. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).
Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012437. PubMed ID: 27855242
[TBL] [Abstract][Full Text] [Related]
3. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
4. Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials.
Graudal N; Hubeck-Graudal T; Tarp S; Christensen R; Jürgens G
PLoS One; 2014; 9(9):e106408. PubMed ID: 25244021
[TBL] [Abstract][Full Text] [Related]
5. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.
Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491
[TBL] [Abstract][Full Text] [Related]
6. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
[TBL] [Abstract][Full Text] [Related]
7. Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.
Graudal N; Jürgens G
Arthritis Rheum; 2010 Oct; 62(10):2852-63. PubMed ID: 20560138
[TBL] [Abstract][Full Text] [Related]
8. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
[TBL] [Abstract][Full Text] [Related]
9. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
Korpela M; Laasonen L; Hannonen P; Kautiainen H; Leirisalo-Repo M; Hakala M; Paimela L; Blåfield H; Puolakka K; Möttönen T;
Arthritis Rheum; 2004 Jul; 50(7):2072-81. PubMed ID: 15248204
[TBL] [Abstract][Full Text] [Related]
10. Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial.
Rantalaiho V; Korpela M; Laasonen L; Kautiainen H; Järvenpää S; Hannonen P; Leirisalo-Repo M; Blåfield H; Puolakka K; Karjalainen A; Möttönen T;
Arthritis Res Ther; 2010; 12(3):R122. PubMed ID: 20576092
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial.
Tavares R; Beattie KA; Bensen WG; Bobba RS; Cividino AA; Finlay K; Goeree R; Hart LE; Jurriaans E; Larche MJ; Parasu N; Tarride JE; Webber CE; Adachi JD
Trials; 2014 Jul; 15():268. PubMed ID: 24997587
[TBL] [Abstract][Full Text] [Related]
12. Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies.
Teitsma XM; Jacobs JWG; Welsing PMJ; Pethö-Schramm A; Borm MEA; van Laar JM; Lafeber FPJG; Bijlsma JWJ
Rheumatology (Oxford); 2018 Feb; 57(2):309-317. PubMed ID: 29095992
[TBL] [Abstract][Full Text] [Related]
13. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
[TBL] [Abstract][Full Text] [Related]
14. Radiological progression of joint damage in a longitudinal cohort of early DMARD-treated rheumatoid arthritis patients followed for 10 years.
Wick MC; Anderwald C; Weiss RJ; Imhof H; Kainberger F; Smolen JS
Scand J Rheumatol; 2004; 33(3):162-6. PubMed ID: 15228186
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction.
Smolen JS; Avila JC; Aletaha D
Ann Rheum Dis; 2012 May; 71(5):687-93. PubMed ID: 22121130
[TBL] [Abstract][Full Text] [Related]
16. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing.
Smolen JS; van der Heijde DM; Aletaha D; Xu S; Han J; Baker D; St Clair EW
Ann Rheum Dis; 2009 Oct; 68(10):1535-40. PubMed ID: 18957487
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of joint structure in patients with rheumatoid arthritis].
Tanaka Y
Clin Calcium; 2013 Mar; 23(3):409-17. PubMed ID: 23445895
[TBL] [Abstract][Full Text] [Related]
18. Conventional monotherapy compared to a "sawtooth" treatment strategy in the radiographic progression of rheumatoid arthritis over the first eight years.
Sokka TM; Kaarela K; Möttönen TT; Hannonen PJ
Clin Exp Rheumatol; 1999; 17(5):527-32. PubMed ID: 10544834
[TBL] [Abstract][Full Text] [Related]
19. Profile and course of early rheumatoid arthritis in Morocco: a two-year follow-up study.
Benbouazza K; Benchekroun B; Rkain H; Amine B; Bzami F; Benbrahim L; Atouf O; Essakalli M; Abouqal R; Dougados M; Hajjaj-Hassouni N
BMC Musculoskelet Disord; 2011 Nov; 12():266. PubMed ID: 22111841
[TBL] [Abstract][Full Text] [Related]
20. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]